Goldberg, Hedley

 

HBI 2022: M&A may slow in H2, but demand remains strong

“We are about to face a global recession,” conceded Hedley Goldberg, managing director at financial advisory group Rothschild, to a packed out audience at the plenary session on the M&A landscape at HBI 2022. “But it will be an unusual one with high levels of inflation and employment.”
July 1, 2022

2022 Health Care M&A Landscape

2021 has been a record year for deal activity and IPOs. But as multiples hit a ceiling, what will happen in 2022? Investors are keeping a watchful eye on inflation, rising wages, energy bills, and overall increased costs of living. The war in Ukraine, sanctions on Russian companies, particularly oil and gas has only added to market […]
June 21, 2022

The post-Covid M&A landscape

Will pent-up investor demand force prices even higher in what most investors view as one of the safest sectors? What has happened to valuations and deal flow through the pandemic? Where are investors particularly focused today? Hedley Goldberg, Rothschild & Co
September 20, 2021

M&A: 2020 and what happens next?

How is Covid affecting valuations for health care service companies in Europe and Emerging Markets. In a detailed data-driven presentation Hedley looks at its impact sector-by-sector. Despite Covid, will cheap money and renewed investor appetite push multiples higher? Followed by a live Q&A session Hedley Goldberg, Managing Director, Rothschild & Co
December 14, 2020

The New Investor and Debt Reality for Healthcare Services

HBI explores the impact of Covid on investors and finances. Panellists include: Rothschild Managing Directors Hedley Goldberg and Helier Drage-Smith, Steven Dyson, Partner, Apax Partners and Angelkia Schöchlin, Senior Partner, Antin
May 20, 2020

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us